Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2007
08/16/2007US20070190076 A bacterial preparation consisting of freeze dried, non-denatured Mycobacterium bovis and water, in an amount effective to stimulate leukocytic regulatory cells, used for the prevention and/or the treatment of cancer, autoimmune diseases, allergies and tuberculosis; vaccines
08/16/2007US20070190073 Bioconjugation; stimulates production of Th1-associated cytokines, lymphocytes, suppresses production of allergen-specific antibodies, reduces allergen-stimulated IgE production
08/16/2007US20070190071 9-Substituted 8-oxoadenine compound
08/16/2007US20070190054 Prevention and treatment of complement-associated disorders
08/16/2007US20070190053 Treament of lupus nephritis with anti-CD40L compounds
08/16/2007US20070190044 Compositions and methods for manipulating levels of antigen-specific antibodies in a mammal
08/16/2007DE60127731T2 Probiotica zur Verwendung als Futter für Haustiere Probiotics for use as food for pets
08/16/2007DE102006005016A1 Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung Conditioned blood composition and process for their preparation
08/16/2007CA2641169A1 Antigenic gm-csf peptides and antibodies to gm-csf
08/16/2007CA2640002A1 Conditioned blood composition and method for its production
08/15/2007EP1818343A2 Antibodies against human IL-12
08/15/2007EP1818341A2 Sheep lice, bovicula ovis, allergen treatment
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1818053A1 Preventive/remedy for allergic diseases
08/15/2007EP1817344A2 ANTI-TNF ALPHA ANTIBODIES WHICH SELECTIVELY INHIBIT TNF ALPHA SIGNALLING THROUGH THE p55R
08/15/2007EP1817337A1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis
08/15/2007EP1817336A2 Auristatins having an aminobenzoic acid unit at the n terminus
08/15/2007EP1817303A2 Substituted pyridines with activity on syk kinase
08/15/2007EP1817301A1 Potentiators of glutamate receptors
08/15/2007EP1817300A1 Potentiators of glutamate receptors
08/15/2007EP1817296A1 Potentiators of glutamate receptors
08/15/2007EP1817279A2 17,20(z)-dehydro vitamin d analogs and their uses
08/15/2007EP1817278A2 2-methylene-18,19-dinor-1alfa-hydroxy-homopregnacalciferol and its uses
08/15/2007EP1817055A2 Ovr110 antibody compositions and methods of use
08/15/2007EP1817054A1 Naturally occuring igm antibodies that bind lymphocytes
08/15/2007EP1817022A2 Methods for increasing the immune response in an animal
08/15/2007EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy
08/15/2007EP1539759B1 Novel imidazopyridines and their use
08/15/2007EP1496059B1 Fused bicyclic pyrimidine derivatives
08/15/2007EP1451196B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics
08/15/2007EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
08/15/2007EP1368372B1 Peptides having affinity for the gp120 viral protein and use thereof
08/15/2007EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
08/15/2007EP1355588B1 Device for delivery of therepeutic agents
08/15/2007EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
08/15/2007EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor
08/15/2007EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
08/15/2007EP1238070B1 Therapeutically useful synthetic oligonucleotides
08/15/2007EP1198254B1 Carrier-drug conjugate
08/15/2007EP1196174B1 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
08/15/2007EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
08/15/2007CN1331853C Small molecule inhibitors of rotamase enzyme activity
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN1331503C Health-care preparation for reducing blood-fat and raising human-body immunity
08/15/2007CN101018853A Method for stabilizing the antiallergic activity of lactic acid bacteria aganst high-temperature treatment, stabilized compositions, and food and drink
08/15/2007CN101018799A Composition and method for inhibiting platelet aggregation
08/15/2007CN101018793A Phosphorylated polyphenols as colour-stable agents
08/15/2007CN101018565A Methods for treating conditions associated with MASP-2 dependent complement activation
08/15/2007CN101018558A Pharmaceutical compositions from carapa guianensis
08/15/2007CN101018549A Cla-enriched milkfat and uses thereof
08/15/2007CN101015688A Molecular antigen array
08/15/2007CN101015680A Medicine for improving immunity and treating malignant tumour and preparation process thereof
08/15/2007CN101015677A Traditional Chinese powder medicine for treating broiler ascites and preparation process thereof
08/15/2007CN101015652A Health-care medicated wine for person in middle and old age
08/15/2007CN101015649A Dendrobium candidum polysaccharide extractive, medicine composition thereof and its preparation and use
08/15/2007CN101015644A Composition and its preparing process
08/15/2007CN101015636A Novel use of Chinese-medicinal composition
08/15/2007CN101015634A Medicine for treating allergic dermatopathy
08/15/2007CN101015622A Medicinal use of radix rehmanniae total glucosides extractive and preparing method thereof
08/15/2007CN101015599A Composite Chinese medicine for treating pollen hypersensitivity symptom
08/15/2007CN101015594A Composition for treating asthma and preparing process thereof
08/15/2007CN101015571A Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
08/15/2007CN101015570A Children's health food of probiotics and its production process
08/15/2007CN101015569A Silkworm powder expressing SOD and preparing method thereof
08/15/2007CN101015559A Instant gelling agent for treating allergic rhinitis
08/15/2007CN101015551A Preparing method of triptolide stereoscopic stable liposome nano granule
08/15/2007CN101015550A Preparing method of triptolide molecule microcapsule
08/15/2007CN101015549A Preparing and detecting method of triptolide liposome nano granule
08/15/2007CN101015410A Pillow with health-care function and its preparing process
08/15/2007CN101015378A Health care beverage with human body immunity increasing function
08/15/2007CN101015377A Health care water with human body immunity increasing function
08/15/2007CN101015345A Health-care food with hypoxia-resistant and immunity-enhancing functions and its preparing process
08/15/2007CN101015315A Cedar leaf tea preparation and its preparing process
08/15/2007CN101015312A Health care functional tea for conditioning subhealthy state
08/14/2007US7256274 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
08/14/2007US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
08/14/2007US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma
08/14/2007US7256194 Compounds that inhibit factor Xa activity
08/14/2007US7256028 Methods for screening compounds that modulate lipid metabolism
08/14/2007US7255868 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
08/14/2007US7255861 Preparations for inducing immunotolerance and uses therefor
08/14/2007CA2354047C Method for the treatment of inflammation
08/14/2007CA2223414C Heteroaryl diol acids as leukotriene antagonists
08/09/2007WO2007089507A1 A3 adenosine receptor allosteric modulators
08/09/2007WO2007089018A1 Triazole derivative
08/09/2007WO2007088895A1 3-arylamino-1,2,4-triazole derivative
08/09/2007WO2007088823A1 ABZYME TO HUMAN TNF-α AND USE THEREOF
08/09/2007WO2007088190A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
08/09/2007WO2007087825A1 Use of a combination of ethanolic rosa sp . , urtica dioica and tanacetum vulgare extracts, further comprising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections
08/09/2007WO2007087673A1 Domain antibody construct
08/09/2007WO2007054283A3 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/09/2007WO2007027751A3 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
08/09/2007WO2006130688A3 Compounds for inhibiting cathepsin activity
08/09/2007WO2006108424A9 Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
08/09/2007WO2006072600A8 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions
08/09/2007US20070186311 BETA 1,2-xylosyltransferase-gene from arabidopsis
08/09/2007US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors
08/09/2007US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists
08/09/2007US20070185122 Use of efletirizine for treating persistent allergic rhinitis
08/09/2007US20070185110 pollinosis, bronchial asthma, atopic dermatitis, urticaria; endometriosis and hysteromyoma
1 ... 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 ... 1172